LONDON & CHICAGO & NEW YORK & HONG KONG--(BUSINESS WIRE)--May 27, 2026--
Options Technology (Options), a leading provider of cloud-enabled managed services for global capital markets, today announced the launch of its Hosted Desktop Infrastructure (HDI) Solution, a next-generation platform engineered to deliver dedicated, GPU-accelerated desktop performance for hedge funds, investment banks, and quantitative trading firms operating in today’s latency-sensitive environments.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527502467/en/
Purpose-built for mission-critical workloads, the HDI Solution provides a high-performance, secure, and scalable alternative to traditional virtual desktop environments. By allocating dedicated 16-core processors, high-capacity memory, and NVIDIA GPU resources to each user, the platform ensures consistent, uncompromised performance across applications such as Bloomberg Terminal, MATLAB, advanced Excel models, and real-time analytics.
Danny Moore, President and CEO of Options, commented: “Historically, complex Excel models and AI environments have posed challenges in cloud environments; with HDI, these models now operate efficiently, reliably, and with a seamless, local-like experience. This solution goes beyond conventional virtual desktop offerings, enabling our clients to perform critical work without compromise.”
Users benefit from ultra-enhanced multi-monitor 4K display capabilities, while seamless integration with platforms including Options’ proprietary Horizon platform and Citrix, alongside tools such as Intune and Puppet, enables flexible deployment across trading floors, hybrid setups, and remote environments.
Security and resilience remain foundational, with all compute resources hosted within Options’ global data centers, incorporating physical safeguards, centralized logging, and automated compliance monitoring. This architecture ensures sensitive data remains protected and centralized, while enabling secure access from any location or device, supported by 24/7 global expertise.
The launch of HDI further strengthens Options' position as a leader in high-performance infrastructure and managed services. Firms can access ready-to-use demo environments via Options' in-house Horizon platform to evaluate performance with no deployment overhead.
Today’s announcement builds on recent milestones at Options, including enhancements to its monitoring tool, AtlasVision, direct access connectivity to Japan Alternative Market (JAX) and the completion of Options’ acquisition of Crossvale.
Options Technology:
Options Technology (Options) is a financial technology company at the forefront of banking and trading infrastructure. We serve clients globally with offices in New York, London, Paris, Belfast, Cambridge, Chicago, Hong Kong, Tokyo, Singapore, Dubai, Sydney and Auckland. At Options, our services are woven into the hottest trends in global technology, including high-performance Networking, Cloud, Security, and AI (Artificial Intelligence).
www.options-it.com
Options Accelerates High-Performance Trading Environments with the Launch of HDI Solution – Redefining Desktop Infrastructure for Global Finance
NEW YORK--(BUSINESS WIRE)--Jun 1, 2026--
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Gossamer Bio, Inc. (“Gossamer” or the “Company”) (NASDAQ: GOSS) and reminds investors of the June 1, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601532429/en/
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that the study design for the Company’s Phase 3 PROSERA study, particularly, controlling for the placebo response at the Latin American testing sites.
On February 23, 2026, Gossamer Bio, Inc. revealed adverse topline results from its Phase 3 PROSERA study, announcing that the trial failed to meet its primary endpoint of improving six-minute walk distance (“6MWD”) at Week 24. While the study reported a placebo-adjusted gain of +13.3 meters, the result did not achieve statistical significance under the prespecified alpha threshold of 0.025 (p=0.0320). The Company attributed the outcome, in part, to unexpectedly strong placebo performance among patients enrolled at Latin American sites, which it characterized as a heavily treated, lower-risk population.
Following this disclosure, investors and analysts reacted swiftly and negatively. On February 23, 2026, Gossamer’s common stock price plummeted from a closing price of $2.13 per share on February 20, 2026 to $0.42 per share, representing a decline of more than 80% in a single trading day.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Gossamer’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Gossamer Bio class action, go to www.faruqilaw.com/GOSS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
CLASS ACTION DEADLINE TONIGHT: Gossamer Bio (GOSS) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 1, 2026 Securities Class Action Deadline
